drugset / Trial / NCT00728208

GSK372475 PK Study in Healthy Volunteers

NCT00728208

Phase 1 Completed 66 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will consist of 4 parallel cohorts of healthy volunteers (elderly male, elderly female, young male and young female). Subjects will receive either GSK372475 1.5mg or placebo for 28 days.

Timeline

Start
2008-07-28
Primary completion
2008-12-29
Completion
2008-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject NS2359 Small molecule 1.5 mg

Indications